Stay tuned
Weighing approval bids from J&J, Pfizer and Roche, FDA scrutinizes data ahead of adcomm
For an upcoming FDA advisory committee meeting, the agency is questio
HHS, DARPA link up with Rutgers, Cost Plus Drugs and others in initiative to rethink US drug production
In a new public-private partnership, the Department of Health and Hum
After 19 months, FDA lifts clinical hold on vaginal yeast infection drug Brexafemme
The FDA has lifted its 19-month clinical hold on vaginal yeast infect
With marketing chief's departure, Omnicom Health loses another exec ahead of Interpublic merger
Craig Romanok, chief marketing officer of Omnicom’s health-focused
WuXi Biologics slims down again, handing off German plant to CDMO Terumo for $167M
The sale allows WuXi Biologics to solely focus on its Singapore capac
Stay tuned
© 1994 - 2025 B.M. Pharmaceuticals